195 related articles for article (PubMed ID: 8359853)
21. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.
Rex JH; Pappas PG; Karchmer AW; Sobel J; Edwards JE; Hadley S; Brass C; Vazquez JA; Chapman SW; Horowitz HW; Zervos M; McKinsey D; Lee J; Babinchak T; Bradsher RW; Cleary JD; Cohen DM; Danziger L; Goldman M; Goodman J; Hilton E; Hyslop NE; Kett DH; Lutz J; Rubin RH; Scheld WM; Schuster M; Simmons B; Stein DK; Washburn RG; Mautner L; Chu TC; Panzer H; Rosenstein RB; Booth J;
Clin Infect Dis; 2003 May; 36(10):1221-8. PubMed ID: 12746765
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
23. The treatment of candidemia.
Tang CM; Howe P; Crook DW
N Engl J Med; 1995 Apr; 332(16):1101; author reply 1101-2. PubMed ID: 7898539
[No Abstract] [Full Text] [Related]
24. [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Thomas F; Mebtouche B; Clavier H; Kalfon P
Rev Pneumol Clin; 2000 Feb; 56(1):37-40. PubMed ID: 10740113
[TBL] [Abstract][Full Text] [Related]
25. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
[TBL] [Abstract][Full Text] [Related]
26. Candida endophthalmitis: focus on current and future antifungal treatment options.
Khan FA; Slain D; Khakoo RA
Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
[TBL] [Abstract][Full Text] [Related]
27. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
28. [Multicenter study of fungemia due to yeasts in Argentina].
Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
[TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
Nolte FS; Parkinson T; Falconer DJ; Dix S; Williams J; Gilmore C; Geller R; Wingard JR
Antimicrob Agents Chemother; 1997 Jan; 41(1):196-9. PubMed ID: 8980781
[TBL] [Abstract][Full Text] [Related]
30. Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis.
Hope WW; Drusano GL; Moore CB; Sharp A; Louie A; Walsh TJ; Denning DW; Warn PA
Antimicrob Agents Chemother; 2007 Jan; 51(1):285-95. PubMed ID: 17088486
[TBL] [Abstract][Full Text] [Related]
31. [Epidemiology of fungemia in a university hospital; therapeutic incidence].
Pavese P; Brion JP; Lebeau B; Grillot R; Ambroise-Thomas P
Pathol Biol (Paris); 1999 May; 47(5):579-83. PubMed ID: 10418046
[TBL] [Abstract][Full Text] [Related]
32. [Phagocytosis of fungi in the peripheral blood neutrophils of two children with cancer during treatment with fluconazole].
Manabe A; Ebihara Y; Saito A; Takahashi K; Hosoya R
Rinsho Ketsueki; 1997 Aug; 38(8):669-73. PubMed ID: 9311273
[TBL] [Abstract][Full Text] [Related]
33. Efficient treatment of murine systemic infection with Candida albicans using amphotericin B incorporated in nanosize range particles (emulsomes).
Kretschmar M; Amselem S; Zawoznik E; Mosbach K; Dietz A; Hof H; Nichterlein T
Mycoses; 2001; 44(7-8):281-6. PubMed ID: 11714063
[TBL] [Abstract][Full Text] [Related]
34. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
Jandourek A; Brown P; Vazquez JA
Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825
[No Abstract] [Full Text] [Related]
35. Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
Myoken Y; Kyo T; Kohara T; Fujihara M; Sugata T; Mikami Y
Clin Infect Dis; 2003 Jun; 36(11):1496-7. PubMed ID: 12766847
[No Abstract] [Full Text] [Related]
36. [Clinical aspects and prognosis of candidemia, a 6-year retrospective study].
Bregenzer T; Evison-Eckstein AC; Frei R; Zimmerli W
Schweiz Med Wochenschr; 1996 Oct; 126(43):1829-33. PubMed ID: 9005522
[TBL] [Abstract][Full Text] [Related]
37. Systemic candidiasis in very low-birth-weight infants (less than 1,500 grams).
Johnson DE; Thompson TR; Green TP; Ferrieri P
Pediatrics; 1984 Feb; 73(2):138-43. PubMed ID: 6694869
[TBL] [Abstract][Full Text] [Related]
38. [Therapy of systemic candidiasis].
Cascioli CF; Balletta M; Donadio P; Liguori M
Minerva Med; 1990 Jun; 81(6):481-3. PubMed ID: 2359504
[TBL] [Abstract][Full Text] [Related]
39. Fluconazole therapy for Candida albicans urinary tract infections in infants.
Triolo V; Gari-Toussaint M; Casagrande F; Garraffo R; Dageville C; Boutté P; Bérard E
Pediatr Nephrol; 2002 Jul; 17(7):550-3. PubMed ID: 12172774
[TBL] [Abstract][Full Text] [Related]
40. The treatment of candidemia.
Cofsky RD
N Engl J Med; 1995 Apr; 332(16):1101; author reply 1101-2. PubMed ID: 7898537
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
